|
Pathogen (n)
|
Antimicrobial non-susceptibility (%)
|
|---|
|
PEN/AMPa
|
COX
|
AMP + BLI
|
CRO
|
GEN
|
CIP
|
CHL
|
CLI
|
ERY
|
SXT
|
TCY
|
|---|
|
S. aureus (312)
|
94.2
|
8.33
|
8.33
|
8.33
|
2.3
|
9.4
|
0.9
|
2.5
|
17.0
|
8.3
|
37.5
|
|
S. pyogenes (69)
|
8.6
|
-
|
-
|
0
|
-
|
-
|
9.1
|
7.8
|
7.9
|
56.0
|
-
|
|
S. pneumoniae (19)
|
6.7
|
-
|
-
|
ND
|
-
|
-
|
14.3
|
10.5
|
11.1
|
82.4
|
ND
|
|
E. faecalis (19)
|
0
|
-
|
-
|
-
|
-
|
81.3
|
-
|
-
|
-
|
-
|
-
|
|
K. pneumoniae (56)
|
100
|
-
|
51.9
|
38.9
|
38.2
|
21.4
|
55.6
|
-
|
-
|
60
|
ND
|
|
P. agglomerans (6)
|
83.3
|
-
|
75.5
|
ND
|
0
|
0
|
ND
|
-
|
-
|
0
|
ND
|
|
P. aeruginosa (39)
|
-
|
-
|
0b
|
0c
|
0d
|
2.6
|
-
|
-
|
-
|
-
|
-
|
|
P. mirabilis (52)
|
34.6
|
-
|
17.3
|
2.1
|
13.5
|
1.9
|
44.4
|
-
|
-
|
48.9
|
ND
|
|
E. coli (114)
|
80.4
|
-
|
60.3
|
16.4
|
14.7
|
24.1
|
35.5
|
-
|
-
|
88.1
|
ND
|
|
S. enterica (9)
|
22.2
|
-
|
ND
|
0
|
0
|
0
|
0
|
-
|
-
|
12.5
|
0
|
- Note: Abbrevations are penicillin/ampicillin (PEN/AMP), cefoxitin (COX), ampicillin plus betalactamase-inhibitor (AMP + BLI), ceftriaxone (CRO), gentamicin (GEN), ciprofloxacin (CIP), chloramphenicol (CHL), clindamycin (CLI), erythromycin (ERY), cotrimoxazole (SXT), tetracycline (TCY), not done (ND). Non-susceptible isolates are shown as the percentage of tested isolates.
-
aShown is the non-susceptibility of Gram-positives to penicillin and the non-susceptibility of Gram-negatives and E. faecalis to ampicillin.
-
bNon-susceptibility to piperacillin/tazobactam.
-
cNon-susceptibility to ceftazidim.
-
dNon-susceptibility to amikacin.
